UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 10, 2017
Accession Number:
Submission Type:
CIK: 0001412486
Company Name: Cocrystal Pharma, Inc.
File Number: 333-220632